Comparative proteomic analysis of Candida albicans and Candida glabrata

Clinical Proteomics

Volumn 6, Issue 4, 2010, Pages 163-173

  Prasad, Thottethodi Subrahmanya Keshava ^a   Keerthikumar, Shivakumar ^a,b   Chaerkady, Raghothama ^a,c   Kandasamy, Kumaran ^a,b,c   Renuse, Santosh ^a,c,d   Marimuthu, Arivusudar ^a,e   Venugopal, Abhilash Karavattu ^a,b,c   Thomas, Joji Kurian ^a   Jacob, Harrys K C ^a,c,e   Goel, Renu ^a,b   Pawar, Harsh ^a,f   Sahasrabuddhe, Nandini A ^a,c,e   Krishna, Venkatarangaiah ^b   Nair, Bipin G ^d   Gucek, Marjan ^g   Cole, Robert N ^h   Ravikumar, Raju ⁱ   Harsha, H C ^a,e   Pandey, Akhilesh ^c  

^a Institute of Bioinformatics   (India)

^b KUVEMPU UNIVERSITY   (India)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d AMRITA UNIVERSITY   (India)

^e MANIPAL UNIVERSITY   (India)

^f RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Biomarker; Candidemia; Candidiasis; Fungal infection; Medical mycology; Molecular diagnostics; Quantitative proteomics

Indexed keywords

ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; PROTEIN; PYRUVATE CARBOXYLASE; PYRUVATE KINASE;

ARTICLE; BIOINFORMATICS; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL FREE SYSTEM; CELL LABELING; CONTROLLED STUDY; DATA BASE; LIQUID CHROMATOGRAPHY; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUADRUPOLE MASS SPECTROMETRY; SPECIES DIFFERENCE;

CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 78649700130     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12014-010-9057-9     Document Type: Article

References (66)

1. MA Pfaller DJ Diekema 2004 Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus J Clin Microbiol 42 10 4419 31 1:CAS:528:DC%2BD2cXpvFKqtLw%3D 10.1128/JCM.42.10.4419-4431.2004 15472288 (Pubitemid 39362350)
2. JA Vazquez 1999 Options for the management of mucosal candidiasis in patients with AIDS and HIV infection Pharmacotherapy 19 1 76 87 1:STN:280:DyaK1M7hsVWiug%3D%3D 10.1592/phco.19.1.76.30509 9917080 (Pubitemid 29031530)
3. MA Pfaller 1996 Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission Clin Infect Dis 22 Suppl 2 S89 94 8722834
4. JR Wingard 1995 Importance of Candida species other than Candida albicans as pathogens in oncology patients Clin Infect Dis 20 1 115 25 1:STN:280:DyaK2M3ksVOiuw%3D%3D 7727637
5. PL Fidel Jr JA Vazquez JD Sobel 1999 Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans Clin Microbiol Rev 12 1 80 96 9880475
6. T Kadir R Pisiriciler S Akyuz A Yarat N Emekli A Ipbuker 2002 Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors J Oral Rehabil 29 5 452 7 1:STN:280:DC%2BD38zhtlOqsw%3D%3D 10.1046/j.1365-2842.2002.00837.x 12028493 (Pubitemid 41697887)
7. MM Canuto FG Rodero VOD Ducasse, et al. 2000 Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients Eur J Clin Microbiol Infect Dis 19 8 593 601 1:CAS:528:DC%2BD3cXns1Gmtrk%3D 10.1007/s100960000323
8. T Fongsmut C Deerochanawong W Prachyabrued 1998 Intraoral Candida in Thai diabetes patients J Med Assoc Thai 81 6 449 53 1:STN:280:DyaK1czktVOhug%3D%3D 9676077
9. SW Redding WR Kirkpatrick BJ Coco, et al. 2002 Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer J Clin Microbiol 40 5 1879 81 10.1128/JCM.40.5.1879-1881.2002 11980984 (Pubitemid 34493182)
10. SW Redding MC Dahiya WR Kirkpatrick, et al. 2004 Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer Oral Surg Oral Med Oral Pathol Oral Radiol Endo 97 1 47 52 10.1016/j.tripleo.2003.09.008 (Pubitemid 38064262)
11. J Bagg MP Sweeney MA Lewis, et al. 2003 High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer Palliat Med 17 6 477 81 1:STN:280:DC%2BD3svmsVOntg%3D%3D 10.1191/0269216303pm793oa 14526879 (Pubitemid 37160885)
12. TA Clark RA Hajjeh 2002 Recent trends in the epidemiology of invasive mycoses Curr Opin Infect Dis 15 6 569 74 12821832
13. EJ Anaissie SE Vartivarian D Abi-Said, et al. 1996 Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study Am J Med 101 2 170 6 1:CAS:528:DyaK28Xlslygs7g%3D 10.1016/S0002-9343(96) 80072-6 8757357 (Pubitemid 26296778)
14. JL Goodman DJ Winston RA Greenfield, et al. 1992 A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation N Engl J Med 326 13 845 51 1:STN:280:DyaK387nvVaqtw%3D%3D 10.1056/NEJM199203263261301 1542320
15. V Krcmery Jr E Oravcova S Spanik, et al. 1998 Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome J Antimicrob Chemother 41 3 373 80 1:CAS:528: DyaK1cXisFGjsrk%3D 10.1093/jac/41.3.373 9578164 (Pubitemid 28151986)
16. RA Hajjeh AN Sofair LH Harrison, et al. 2004 Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J Clin Microbiol 42 4 1519 27 10.1128/JCM.42.4.1519-1527.2004 15070998 (Pubitemid 38500790)
17. L Willocks CL Leen RP Brettle D Urquhart TB Russell LJ Milne 1991 Fluconazole resistance in AIDS patients J Antimicrob Chemother 28 6 937 9 1:STN:280:DyaK383ns1WgtA%3D%3D 10.1093/jac/28.6.937 1816193
18. CA Hitchcock GW Pye PF Troke EM Johnson DW Warnock 1993 Fluconazole resistance in Candida glabrata Antimicrob Agents Chemother 37 9 1962 5 1:CAS:528:DyaK2cXislejsA%3D%3D 8239613
19. SW Redding RC Zellars WR Kirkpatrick, et al. 1999 Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer J Clin Microbiol 37 12 3896 900 1:STN:280: DC%2BD3c%2FjtlKhtg%3D%3D 10565903
20. SW Redding 2001 The role of yeasts other than Candida albicans in oropharyngeal candidiasis Curr Opin Infect Dis 14 6 673 7 1:STN:280: DC%2BD383ivVWhuw%3D%3D 11964883
21. AA Panackal JL Gribskov JF Staab KA Kirby M Rinaldi KA Marr 2006 Clinical significance of azole antifungal drug cross-resistance in Candida glabrata J Clin Microbiol 44 5 1740 3 1:CAS:528:DC%2BD28XltlGnsrw%3D 10.1128/JCM.44.5.1740- 1743.2006 16672401 (Pubitemid 43726263)
22. HM Valerio Rde C Weikert-Oliveira MA Resende 2006 Differentiation of Candida species obtained from nosocomial candidemia using RAPD-PCR technique Rev Soc Bras Med Trop 39 2 174 8 10.1590/S0037-86822006000200008 16699645
23. MA Santos C el-Adlouni AD Cox JM Luz G Keith MF Tuite 1994 Transfer RNA profiling: a new method for the identification of pathogenic Candida species Yeast 10 5 625 36 1:CAS:528:DyaK2cXksFensLY%3D 10.1002/yea.320100507 7941747 (Pubitemid 24178982)
24. M Essendoubi D Toubas M Bouzaggou JM Pinon M Manfait GD Sockalingum 2005 Rapid identification of Candida species by FT-IR microspectroscopy Biochim Biophys Acta 1724 3 239 47 1:CAS:528:DC%2BD2MXntVGjt7s%3D 15951116
25. N Gupta A Haque AA Lattif RP Narayan G Mukhopadhyay R Prasad 2004 Epidemiology and molecular typing of Candida isolates from burn patients Mycopathologia 158 4 397 405 10.1007/s11046-004-1820-x 15630548
26. T Jones NA Federspiel H Chibana, et al. 2004 The diploid genome sequence of Candida albicans Proc Natl Acad Sci USA 101 19 7329 34 1:CAS:528: DC%2BD2cXksFaksLw%3D 10.1073/pnas.0401648101 15123810 (Pubitemid 38638032)
27. M van het Hoog TJ Rast M Martchenko, et al. 2007 Assembly of the Candida albicans genome into sixteen supercontigs aligned on the eight chromosomes Genome Biol 8 4 R52 10.1186/gb-2007-8-4-r52 (Pubitemid 351859210)
28. B Dujon D Sherman G Fischer, et al. 2004 Genome evolution in yeasts Nature 430 6995 35 44 10.1038/nature02579 15229592 (Pubitemid 38915217)
29. SA Lachke S Joly K Daniels DR Soll 2002 Phenotypic switching and filamentation in Candida glabrata Microbiology 148 Pt 9 2661 74 1:CAS:528:DC%2BD38Xnt1eltbg%3D 12213913
30. A Chakrabarti N Nayak P Talwar 1991 In vitro proteinase production by Candida species Mycopathologia 114 3 163 8 1:CAS:528:DyaK38XlsFWqtA%3D%3D 10.1007/BF00437209 1886642
31. BB Magee B Hube RJ Wright PJ Sullivan PT Magee 1993 The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members Infect Immun 61 8 3240 3 1:CAS:528:DyaK3sXmtFyqs7g%3D 8335356
32. M Monod G Togni B Hube D Sanglard 1994 Multiplicity of genes encoding secreted aspartic proteinases in Candida species Mol Microbiol 13 2 357 68 1:CAS:528:DyaK2cXmslegu7w%3D 10.1111/j.1365-2958.1994.tb00429.x 7984113 (Pubitemid 24225506)
33. GD Gilfillan DJ Sullivan K Haynes T Parkinson DC Coleman NA Gow 1998 Candida dubliniensis: phylogeny and putative virulence factors Microbiology 144 Pt 4 829 38 1:CAS:528:DyaK1cXivFKrtb4%3D 10.1099/00221287-144-4-829 9579058
34. C Zaugg M Borg-Von Zepelin U Reichard D Sanglard M Monod 2001 Secreted aspartic proteinase family of Candida tropicalis Infect Immun 69 1 405 12 10.1128/IAI.69.1.405-412.2001 11119531 (Pubitemid 32038339)
35. B Hube J Naglik 2001 Candida albicans proteinases: resolving the mystery of a gene family Microbiology 147 Pt 8 1997 2005 1:CAS:528:DC%2BD3MXmt12qurc%3D 11495978 (Pubitemid 32785481)
36. IE Frohner C Bourgeois K Yatsyk O Majer K Kuchler 2009 Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance Mol Microbiol 71 1 240 52 1:CAS:528:DC%2BD1MXptFSmsw%3D%3D 10.1111/j.1365-2958.2008.06528.x 19019164
37. K Barrett-Bee Y Hayes RG Wilson JF Ryley 1985 A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts J Gen Microbiol 131 5 1217 21 1:STN:280:DyaL2M3mtlGhtQ%3D%3D 3894572
38. Y Banno T Yamada Y Nozawa 1985 Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties Sabouraudia 23 1 47 54 1:CAS:528:DyaL2MXktVehurw%3D 3887602
39. GT Cole KT Lynn KR Seshan 1990 An animal model for oropharyngeal, esophageal and gastric candidosis Mycoses 33 1 7 19 1:STN:280: DyaK3c3lvFSisg%3D%3D 2342521
40. AS Ibrahim F Mirbod SG Filler, et al. 1995 Evidence implicating phospholipase as a virulence factor of Candida albicans Infect Immun 63 5 1993 8 1:CAS:528:DyaK2MXlt1amtLw%3D 7729913
41. M Takahashi Y Banno Y Nozawa 1991 Secreted Candida albicans phospholipases: purification and characterization of two forms of lysophospholipase-transacylase J Med Vet Mycol 29 3 193 204 1:STN:280: DyaK3Mzms1Giuw%3D%3D 10.1080/02681219180000291 1890563
42. YH Samaranayake TW MacFarlane LP Samaranayake T Aitchison 1994 The in vitro proteolytic and saccharolytic activity of Candida species cultured in human saliva Oral Microbiol Immunol 9 4 229 35 1:CAS:528:DyaK2cXmsFSktrs%3D 10.1111/j.1399-302X.1994.tb00063.x 7478763
43. N Al-Rawi K Kavanagh 1999 Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women Br J Biomed Sci 56 2 99 104 1:STN:280:DC%2BD3c7lvFeksA%3D%3D 10695049
44. M Schaller R Mailhammer G Grassl CA Sander B Hube HC Korting 2002 Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence J Invest Dermatol 118 4 652 7 1:CAS:528:DC%2BD38Xjt1Cisr0%3D 10.1046/j.1523-1747.2002.01699.x 11918712 (Pubitemid 34309985)
45. L Li A Dongari-Bagtzoglou 2007 Oral epithelium-Candida glabrata interactions in vitro Oral Microbiol Immunol 22 3 182 7 1:CAS:528: DC%2BD2sXntFOlsLs%3D 10.1111/j.1399-302X.2007.00342.x 17488444 (Pubitemid 46691093)
46. L Li H Kashleva A Dongari-Bagtzoglou 2007 Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models Microb Pathog 42 4 138 47 1:CAS:528:DC%2BD2sXkt1aktr8%3D 10.1016/j.micpath.2006.12.003 17306958 (Pubitemid 46551640)
47. Y Abiko M Saitoh M Nishimura M Yamazaki D Sawamura T Kaku 2007 Role of beta-defensins in oral epithelial health and disease Med Mol Morphol 40 4 179 84 1:CAS:528:DC%2BD2sXhsVelsLjI 10.1007/s00795-007-0381-8 18085375 (Pubitemid 350277687)
48. Z Feng B Jiang J Chandra M Ghannoum S Nelson A Weinberg 2005 Human beta-defensins: differential activity against candidal species and regulation by Candida albicans J Dent Res 84 5 445 50 1:CAS:528:DC%2BD2MXltVWlsro%3D 10.1177/154405910508400509 15840781 (Pubitemid 43827877)
49. S Vylkova N Nayyar W Li M Edgerton 2007 Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption Antimicrob Agents Chemother 51 1 154 61 1:CAS:528: DC%2BD2sXktVaksA%3D%3D 10.1128/AAC.00478-06 17074797 (Pubitemid 46047700)
50. EJ Helmerhorst C Venuleo A Beri FG Oppenheim 2005 Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins Yeast 22 9 705 14 1:CAS:528:DC%2BD2MXosVehs7g%3D 10.1002/yea.1241 16034806 (Pubitemid 41149949)
51. EJ Helmerhorst C Venuleo D Sanglard FG Oppenheim 2006 Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5 Antimicrob Agents Chemother 50 3 1100 3 1:CAS:528:DC%2BD28XisFamur0%3D 10.1128/AAC.50.3.1100-1103.2006 16495279 (Pubitemid 43327821)
52. N Beckloff D Laube T Castro, et al. 2007 Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens Antimicrob Agents Chemother 51 11 4125 32 1:CAS:528:DC%2BD2sXht1ygtLrP 10.1128/AAC.00208-07 17785509 (Pubitemid 350057814)
53. G Butler MD Rasmussen MF Lin, et al. 2009 Evolution of pathogenicity and sexual reproduction in eight Candida genomes Nature 459 7247 657 62 1:CAS:528:DC%2BD1MXmtlars7Y%3D 10.1038/nature08064 19465905
54. R Chaerkady HC Harsha A Nalli, et al. 2008 A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma J Proteome Res 7 10 4289 98 1:CAS:528:DC%2BD1cXhtVSrtLbI 10.1021/pr800197z 18715028
55. I Miranda R Rocha MC Santos, et al. 2007 A genetic code alteration is a phenotype diversity generator in the human pathogen Candida albicans PLoS ONE 2 10 e996 10.1371/journal.pone.0000996 17912373 (Pubitemid 351472454)
56. RM Silva JA Paredes GR Moura, et al. 2007 Critical roles for a genetic code alteration in the evolution of the genus Candida EMBO J 26 21 4555 65 1:CAS:528:DC%2BD2sXht1emtbjJ 10.1038/sj.emboj.7601876 17932489 (Pubitemid 350036632)
57. AC Gomes I Miranda RM Silva, et al. 2007 A genetic code alteration generates a proteome of high diversity in the human pathogen Candida albicans Genome Biol 8 10 R206 10.1186/gb-2007-8-10-r206 17916231 (Pubitemid 351917468)
58. A Rodaki T Young AJ Brown 2006 Effects of depleting the essential central metabolic enzyme fructose-1, 6-bisphosphate aldolase on the growth and viability of Candida albicans: implications for antifungal drug target discovery Eukaryot Cell 5 8 1371 7 1:CAS:528:DC%2BD28Xos1Gquro%3D 10.1128/EC.00115-06 16896220
59. LE Cowen 2009 Hsp90 orchestrates stress response signaling governing fungal drug resistance PLoS Pathog 5 8 e1000471 10.1371/journal.ppat.1000471 19714223
60. SD Singh N Robbins AK Zaas WA Schell JR Perfect LE Cowen 2009 Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin PLoS Pathog 5 7 e1000532 10.1371/journal.ppat.1000532 19649312
61. Muerhoff AS, Birkenmeyer LG, Coffey R, et al. Detection of Plasmodium falciparum, vivax, ovale and malariae MSP1-p19 antibodies in human malaria patients and experimentally infected non-human primates. Clin Vaccine Immunol. 2010. doi: 10.1128/CVI.00196-10
62. L Birkenmeyer AS Muerhoff GJ Dawson SM Desai 2010 Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovale Am J Trop Med Hyg 82 6 996 1003 1:CAS:528:DC%2BC3cXosl2hsr4%3D 10.4269/ajtmh.2010.09-0022 20519591
63. P Gillet DP van Dijk E Bottieau L Cnops M Van Esbroeck J Jacobs 2009 Test characteristics of the SD FK80 Plasmodium falciparum/Plasmodium vivax malaria rapid diagnostic test in a non-endemic setting Malar J 8 262 10.1186/1475-2875-8-262 19930609
64. R Lima Mda RM Nogueira HG Schatzmayr FB dos Santos 2010 Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil PLoS Negl Trop Dis 4 7 e738 10.1371/journal.pntd. 0000738 20625558
65. LW Qiu B Di K Wen, et al. 2009 Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections Clin Vaccine Immunol 16 1 88 95 1:CAS:528: DC%2BD1MXht1Sksbc%3D 10.1128/CVI.00212-08 19020106
66. M Junqueira V Spirin TS Balbuena, et al. 2008 Protein identification pipeline for the homology-driven proteomics J Proteomics 71 3 346 56 1:CAS:528:DC%2BD1cXhtVSiu7zK 10.1016/j.jprot.2008.07.003 18639657